Accenture CEO To Step Down After 8 Years In The Role For Health Reasons

Accenture PLC ACN, >+0.02% said Friday Chairman and Chief Executive Pierre Nanterme has stepped down, after 8 years as CEO, for health reasons. the company has named Chief Financial Officer David Rowland as interim CEO; KC McClure, who currently leads finance operations, as CFO; and Lead Independent Director Marge Magner as its non-executive chair. In July 2016, the company disclosed that Nanterme was diagnosed with colon cancer. The business consultant said there was no change to its outlook for the fiscal second quarter or fiscal 2019. The stock was little changed in premarket trade. It has lost 7.6% over the past 12 months while the S&P 500 SPX, >+0.37% has declined 6.2%.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Source :

Accenture CEO to step down after 8 years in the role for health reasons
Accenture CEO Pierre Nanterme Steps Down for Health Reasons
ACN Stock Slips as Accenture CEO Steps Down
Accenture Chairman & CEO Pierre Nanterme Steps Down; Names Rowland Interim CEO
Accenture's former CEO Pierre Nanterme passes away
Accenture CEO Pierre Nanterme steps down due to health reasons
Accenture CEO steps down due to health reasons
Accenture CEO Pierre Nanterme Stepping Down for Health Reasons